Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Bifidobacterium Animalis Subsp. Lactis BLa36 on Gastrointestinal Function, Inflammatory and Immune Responses, and Gut Microbiota in Adults With Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
Conditions
Interventions
Probiotic
Maltodextrin
Locations
1
China
Suzhou Ninth People's Hospital
Suzhou, Jiangsu, China
Start Date
April 15, 2026
Primary Completion Date
November 30, 2026
Completion Date
January 20, 2027
Last Updated
April 2, 2026
NCT07091084
NCT06196073
NCT07536698
NCT07336589
NCT07002489
NCT06506136
Lead Sponsor
Wecare Probiotics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions